Jeff brings more than 30 years of commercial leadership experience across marketing, sales, market access, business development, and operations, with therapeutic depth spanning oncology, hematology, CNS, gastroenterology, and infectious diseases. As Chief Revenue Officer and a member of the Valeris Executive Committee, he leads commercial execution across the organization.

He joins Valeris from Syndax Pharmaceuticals, where he served as SVP, Commercial, building the oncology biotech's inaugural sales, marketing, clinical educator, and training functions ahead of the launch of its first two first-in-class assets.

Earlier in his career, Jeff was a foundational commercial hire at SK Life Science, where he helped build the market development, marketing, sales, and training functions behind a major epilepsy therapy launch, delivered at the height of the COVID-19 pandemic. He began his career at Johnson & Johnson's pharmaceutical division.